Plus Therapeutics (PSTV) CEO pay: $4.7M actually paid in FY2025
$PSTV · PLUS THERAPEUTICS, INC.Data through FY2025 — latest proxy filed 2026-03-31, checked for new filings 2026-08-21. Every number links to its source.
1.2× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2022 | Same, peer group since FY2022 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $5.6M | $4.7M | $1.5M | $11.00 | — | -$22.4M |
| 2024 | $1.3M | $1.6M | $1.1M | $4.00 | — | -$13.0M |
| 2023 | $1.1M | $1.6M | $1.6M | $6.00 | — | -$13.3M |
| 2022 | $954,651 | $1.6M | $1.6M | $30.00 | — | -$20.3M |
Frequently asked
How much did the PSTV CEO make in 2025?
$4,732,191 in Compensation Actually Paid (CAP) as PLUS THERAPEUTICS, INC.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-03-31.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on PSTV: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary